# Compliance with monitoring for lithium-associated neurotoxicity in psychiatric inpatients: a retrospective audit - URL: https://alisanburak.com/en/wcp-2026-posterler/so066 - Language: en - Last updated: not specified - Page title: Compliance with monitoring for lithium-associated neurotoxicity in psychiatric inpatients: a retrospective audit | WCP 2026 Summary > Assessment for neurotoxicity on admission was documented in only 61.5% of inpatients taking lithium, while lithium level measurement had the lowest compliance… This page was translated automatically from Turkish. [Read the original](https://alisanburak.com/wcp-2026-posterler/so066) Bu sayfa, 26. Dünya Psikiyatri Kongresi'nde sunulan çalışmanın yapay zekâ desteğiyle hazırlanmış Türkçe özetidir. Çalışmanın sahibi sunan yazarlardır; atıf için orijinal kaynağa başvurun. SO066 Kısa Sözlü Poster SunumuPsikofarmakolojiGeriye dönük klinik denetim # Compliance with monitoring for lithium-associated neurotoxicity in psychiatric inpatients: a retrospective audit COMPLIANCE WITH LITHIUM-ASSOCIATED NEUROTOXICITY MONITORING IN PSYCHIATRIC INPATIENTS: A RETROSPECTIVE AUDIT Sunan: Roman H. Limbu Ülke: United Kingdom Kurum: RDaSH NHS Foundation Trust Oturum: 2760 - PARALLEL SHORT ORAL POSTER SESSIONS: MISCELLANEOUS - Part II Tarih: Thu, 24.09.2026 Assessment for neurotoxicity on admission was documented in only 61.5% of inpatients taking lithium, while lithium level measurement had the lowest compliance among the monitoring measures (23.1%). The aim of the audit was to assess compliance with documentation of neurological monitoring for lithium toxicity in psychiatric inpatients prescribed lithium; secondary aims were to measure compliance with biochemical monitoring and identify gaps to inform targeted quality improvement initiatives. The poster emphasises that lithium has a narrow therapeutic index, that neurotoxicity can occur even at therapeutic serum levels, and that its manifestations may include confusion, tremor, ataxia and seizures. The study was a retrospective clinical audit of electronic health records over a twelve-month period in adult psychiatric inpatient wards within an NHS trust (RDaSH); it included 15 adult admissions, of whom 13 were already taking lithium and 2 started it during admission. The primary criterion was documentation of at least two of the following: confusion, paraesthesia, tremor and ataxia. Secondary criteria were urea and electrolytes and estimated glomerular filtration rate (U&Es/eGFR) and thyroid function tests (TFTs) within 24 hours, and a lithium level within 72 hours when clinically indicated. The audit target was 100% compliance, and the data were analysed descriptively. Neurological monitoring was documented in 8 of the 13 eligible admissions (61.5%) and was not documented in 5 (38.5%); lithium levels were measured within 72 hours in only 3 of 13 patients (23.1%), while renal function tests were performed within 24 hours in 9 of 15 patients (60.0%) and thyroid function tests in 6 (40.0%). The conference abstract additionally reports that liver function tests were completed in 11 of 15 patients (73.3%), making this the measure with the highest compliance. Renal monitoring was found to be more reliable than thyroid monitoring, although timely U&Es/eGFR testing was not performed in 40% of admissions. In conclusion, neurological monitoring on admission was inconsistently documented, biochemical monitoring varied, and there was marked non-compliance with lithium level measurement. To improve practice, the poster recommends monthly multidisciplinary educational meetings and a standardised blood monitoring checklist embedded in the admission workflow. It identifies the small sample (n=15) and retrospective record-based review as limitations and outlines plans for a repeat audit following the intervention. [Orijinal postere git](https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/1421) Bu çalışmaya nasıl atıf yapılır? APA 7: Limbu, R. H., et al. (2026, September 24). Compliance with lithium-associated neurotoxicity monitoring in psychiatric inpatients: a retrospective audit [Poster presentation]. 26th WPA World Congress of Psychiatry (WCP 2026), Stockholm, Sweden. https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/1421 Vancouver: Limbu RH, et al. Compliance with lithium-associated neurotoxicity monitoring in psychiatric inpatients: a retrospective audit [poster]. 26th WPA World Congress of Psychiatry (WCP 2026); 2026 Sep 23-26; Stockholm, Sweden. Available from: https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/1421 Yazar adları ve başlık biçimi kongre sisteminden otomatik oluşturulmuştur; kullanmadan önce orijinal posterle karşılaştırın. ## Aynı konudan - [Açığı kapatmak: erişkin DEHB ilacı başlanmadan önce EKG sevk uyumunun iyileştirilmesi, kapalı döngü klinik denetim](https://alisanburak.com/en/wcp-2026-posterler/ev0088) - [Anksiyete bozukluğu olan hastalarda psikobiyotik müdahalesi: ısıl işlem görmüş Lactobacillus paracasei PS23'ün etkilerini inceleyen çift kör randomize kontrollü çalışma](https://alisanburak.com/en/wcp-2026-posterler/ev0126) - [Otizm spektrum bozukluğunda bumetanidin tedavi edici potansiyeli: güncel kanıtlar ve gelecek yönelimleri](https://alisanburak.com/en/wcp-2026-posterler/ev0157) - [Verbaskozid ile otizm spektrum bozukluğu tedavisinin mekanizmaları: ağ farmakolojisi, moleküler yerleştirme ve moleküler dinamik temelli inceleme](https://alisanburak.com/en/wcp-2026-posterler/ev0172) - [Otizm spektrum bozukluğunun çekirdek belirtilerinin tedavisinde kannabidiol: sistematik derleme](https://alisanburak.com/en/wcp-2026-posterler/ev0186) [Tüm WCP 2026 özetleri](https://alisanburak.com/en/wcp-2026-posterler) --- Kaynak / Source: https://alisanburak.com/en/wcp-2026-posterler/so066 İletişim / Contact: Bağdat Caddesi, Veli Güneysu Apt. No:453 K:4 D:9, Suadiye / Kadıköy, İstanbul · +90 532 642 95 25 · info@alisanburak.com · https://alisanburak.com/bagdat-caddesi-psikoterapi-iletisim